Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

OOnKure Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
O

OnKure Therapeutics, Inc.

$3.10Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
2024202020212022202320242026-50M-40M-30M-20M-10M0Latest period 2024. Revenue 0. Gross profit 0. Net profit -52.67M.
RevenueGross profitNet profit
See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
20242020202120222023202420260%0%0%0%0%Latest period 2024. No revenue — margins undefined.
Gross marginOperating marginNet profit marginNo revenue (margins undefined)
Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
$
2025202020212022202320242025-50M-40M-30M-20M-10M0
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    Latest period 2025. Operating cash flow -51.8M. Capex -46K. Free cash flow -51.9M.
    Operating cash flowCapexFree cash flow
    Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
    20262020202120222023202420252026050M100M150M
        Latest period 2026. Cash 166.5M. Debt 0.
        CashDebtNet cash
        Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
        $/shareUsing split history cached 2026-09-23; assuming no new splits
        2025202020212022202320242025-100.00-80.00-60.00-40.00-20.000.00
          • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 2,053,070 source shares.
          • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 24,455,390 source shares.
          • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 24,699,553 source shares.
          • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 3,342,034 source shares.
          • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 13,347,117 source shares.
          • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 13,673,565 source shares.
          Latest period FY 2025. EPS (TTM) -4.35.
          EPS (TTM)
          How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
          Using split history cached 2026-09-23; assuming no new splits
          historical price missing or staleMissing2025202020212022202320242025-6x-4x-2x0x
          • FY 2020: historical price missing or stale
          • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 2,053,070 source shares.
          • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 24,455,390 source shares. Weekly price on 2021-12-31.
          • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 24,699,553 source shares. Nearby weekly price on 2022-12-30.
          • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 3,342,034 source shares. Nearby weekly price on 2023-12-29.
          • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 13,347,117 source shares. Nearby weekly price on 2025-01-03.
          • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 13,673,565 source shares. Nearby weekly price on 2026-01-02.
          Latest period FY 2025. P/E ratio -0.7x.
          P/E ratio
          See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
          Stock split history may be out of date.
          20262020202120222023202420252026010M20M30M40M
          2024-10-07: Reverse stock split 1-for-10
              Latest period Shares as of 2026-06-30. Shares outstanding 40.5M. Class detail unavailable 40.5M.
              Class detail unavailableStock split